澳大利亚血液系统恶性肿瘤成人疫苗接种服务创新建议:一项横断面调查研究
该研究在澳大利亚开展在线横断面调查,邀请接受过血液系统恶性肿瘤治疗者参与,以识别疫苗接种的障碍、促进因素和偏好。共纳入87份应答,结果显示疫苗的经济和时间成本是重要障碍,对副作用的恐惧和免疫原性降低的担忧常见;共享护理模式有便利潜力,但保持与专科护理的联系被认为至关重要。
要点
- 疫苗的经济和时间成本是血液系统恶性肿瘤患者接种的重要障碍。
- 对副作用的恐惧和免疫原性降低的担忧在该人群中常见。
- 共享护理模式有便利潜力,但保持专科护理联系被认为至关重要。
核心结论
- 研究生成全球首个证据,揭示血液系统恶性肿瘤患者疫苗接种的障碍、促进因素和偏好,以指导更可接受、可及和适宜的接种服务模式。
研究设计与样本
- 在澳大利亚开展的在线横断面调查,采用非概率样本,通过相关支持组织广告邀请接受过血液系统恶性肿瘤治疗者参与。
- 调查由研究团队基于既往研究设计,包含5个部分和30个短答、单选、多选和评分条目。
主要发现
- 共87份应答纳入分析。
- 疫苗的经济和时间成本是接种的重要障碍。
- 对副作用的恐惧和免疫原性降低的担忧常见。
- 共享护理模式被认为有便利潜力,但保持与专科护理的联系被认为至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: People affected by haematological malignancies are at high risk of vaccine-preventable diseases due to the immunosuppressive effects of their cancer, treatment and reduced immunogenicity. However, evidence suggests that members of this population suboptimally complete suggested vaccination schedules during and after treatment. This study was undertaken to identify barriers, enablers, and preferences to vaccination to inform service innovation. METHODS: An online cross-sectional survey was disseminated in Australia. A non-probabilistic sample of people who had received treatment for a haematological malignancy were invited to take part via advertisements through relevant support organisations. The survey was specifically designed from previous research undertaken by the authorship team and comprised 5 sections and 30 short answer, single and multiple choice, and rating items. Topics explored included: participant characteristics, experiences of primary care and vaccination, perceptions of barriers and enablers, and preferences regarding vaccination delivery models. All quantitative survey items were analysed descriptively and presented in tables and graphs as appropriate. Qualitative open-text items were analysed using content analysis. RESULTS: A total of 87 responses were included in analysis. Survey responses confirmed that financial and time costs of vaccinations were considerable barriers to uptake, and concerns regarding fear of side effects and reduced immunogenicity were common. While people saw potential convenience benefits of shared care models, remaining linked into specialist care was perceived to be crucial. Findings were synthesised to produce recommendations. CONCLUSION: This study has generated world-first evidence investigating the barriers, enablers, and preferences of people affected by haematological malignancies regarding vaccination to inform more acceptable, accessible, and appropriate models of delivery.
引用
- Chung H, Krishnasamy M, Joyce T, et al. Recommendations for innovation in vaccination services for adults with haematological malignancies: an Australian cross-sectional survey study. Vaccine. 2025. PMID: 40738003. doi:10.1016/j.vaccine.2025.127539
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。